Opportunity Information: Apply for PAR 18 228

The NIH funding opportunity PAR 18-228, titled "Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R34 Clinical Trial Required)," supports early-stage, pilot clinical trial research focused on reducing suicide-related outcomes among young people who interact with the juvenile justice system. The core idea is to test the effectiveness of approaches that do two things together: (1) improve detection of suicide risk, suicidal thoughts, and non-suicidal self-injury (NSSI), and (2) deliver practical interventions aimed at preventing escalation to self-harm or suicide behavior. Rather than funding large definitive trials, this R34 mechanism is geared toward pilot testing and building a solid evidence base and implementation pathway for larger follow-on studies.

A key feature of this opportunity is its emphasis on real-world juvenile justice touchpoints where prevention can realistically happen. The FOA highlights that risk detection and prevention opportunities begin very early, including first contacts such as police interactions or intake interviews, and continue across multiple settings and decision points like pre-trial detention, juvenile or family court proceedings, court disposition, placement decisions, and ongoing care in residential facilities or community supervision and service settings. In practice, this means applicants are encouraged to design strategies that can be embedded throughout the youth justice pathway, including moments that are often chaotic or time-pressured, where staff need usable tools and clear workflows.

The FOA also pushes applicants to focus on interventions that are feasible in typical service environments using commonly available staff, resources, and infrastructure. In other words, the goal is not to create an idealized program that only works with highly specialized clinicians or exceptional funding. Instead, NIH is looking for combined detection-and-intervention strategies that juvenile justice agencies, courts, detention centers, and community programs could realistically deliver through existing personnel and routine operations. This implementation-oriented focus is meant to increase the chances that strategies proven effective in the pilot phase can be adopted more widely across diverse jurisdictions and settings, ultimately reducing suicide and self-harm risk in this high-vulnerability population.

Administratively, this is a discretionary grant program within the NIH health research portfolio (CFDA 93.242). The funding instrument is a grant, and the award ceiling listed is $225,000. The opportunity record indicates an original closing date of 2021-01-07, and a creation date of 2017-11-17, which is helpful for understanding the timeframe of the announcement and that applicants should verify current status and any reissued or updated versions if they are planning a submission now.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and Indian/Native American tribal governments that are not federally recognized.

At the same time, the FOA places clear limits on foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible to apply. In addition, foreign components, as NIH defines them in the NIH Grants Policy Statement, are not allowed under this opportunity. Practically, that means the applicant organization and the work supported by the award must remain domestic in scope and structure under NIH policy for this FOA.

Overall, this opportunity is aimed at generating actionable, scalable evidence on how to identify suicide risk and deliver prevention support for justice-involved youth across the points in the system where youth are assessed, detained, adjudicated, placed, and supervised. The strongest-fit projects are likely to be those that pair a workable detection approach (such as structured screening and risk triage processes) with an intervention that can be delivered with routine staffing and resources, while also paying attention to implementation in the messy realities of juvenile justice settings.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R34 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2017-11-17.
  • Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $225,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 228

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)

Previous opportunity: FY 2018 Study of the U.S. Institutes for Student Leaders on Women's Leadership

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 228

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 228) also looked into and applied for these:

Funding Opportunity
Limited Competition: RCMI Research Coordination Network (RRCN) (U54) Apply for RFA MD 18 001

Funding Number: RFA MD 18 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) Apply for PAR 18 233

Funding Number: PAR 18 233
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) Apply for PAR 18 232

Funding Number: PAR 18 232
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional) Apply for PAR 18 244

Funding Number: PAR 18 244
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21 Clinical Trial Optional) Apply for PAR 18 245

Funding Number: PAR 18 245
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) Apply for PAR 18 262

Funding Number: PAR 18 262
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 18 268

Funding Number: PAR 18 268
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Epidemiology and Prevention in Alcohol Research (R03 - Clinical Trial - Optional) Apply for PA 18 413

Funding Number: PA 18 413
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional) Apply for PAS 18 120

Funding Number: PAS 18 120
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional) Apply for PAR 18 184

Funding Number: PAR 18 184
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional) Apply for PAR 18 186

Funding Number: PAR 18 186
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Wearable Alcohol Biosensors (R43/R44 Clinical Trial Optional) Apply for PAR 18 204

Funding Number: PAR 18 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional) Apply for PAS 18 121

Funding Number: PAS 18 121
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional) Apply for PA 18 390

Funding Number: PA 18 390
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Epidemiology and Prevention in Alcohol Research (R21 - Clinical Trial Optional) Apply for PA 18 391

Funding Number: PA 18 391
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional) Apply for PAR 18 183

Funding Number: PAR 18 183
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional) Apply for PAR 18 185

Funding Number: PAR 18 185
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional) Apply for PAR 18 269

Funding Number: PAR 18 269
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NHLBI Career Transition Award for Intramural Fellows (K22) (Clinical Trials Required) Apply for PAR 18 424

Funding Number: PAR 18 424
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NHLBI Career Transition Award for Intramural Fellows (K22) (No Independent Clinical Trials) Apply for PAR 18 416

Funding Number: PAR 18 416
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 228", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: